Research progress in live attenuated Brucella vaccine development

Current Pharmaceutical Biotechnology

Volumn 14, Issue 10, 2013, Pages 887-896

  Wang, Zhen ^a,b   Wu, Qingmin ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF AGRICULTURE   (China)

Author keywords

Brucella; Brucellosis; Intracellular pathogen; Research progress; Vaccine

Indexed keywords

BRUCELLA VACCINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOPLASM PROTEIN; GLYCOSYLTRANSFERASE; HEAT SHOCK PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIVE VACCINE; MEMBRANE PROTEIN; NITRIC OXIDE REDUCTASE; OUTER MEMBRANE PROTEIN; PERIPLASMIC BINDING PROTEIN; PHOSPHOGLUCOMUTASE; PHOSPHOMANNOMUTASE; REGULATOR PROTEIN; RIBOSOME PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUXOTROPHY; BACTERIAL VIRULENCE; BRUCELLOSIS; COLONY FORMING UNIT; DEVELOPMENTAL SCREENING; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TYPE IV SECRETION SYSTEM; VACCINATION; VACCINE PRODUCTION;

ANIMALS; BIOMEDICAL RESEARCH; BRUCELLA; BRUCELLA VACCINE; BRUCELLOSIS; BRUCELLOSIS, BOVINE; CATTLE; DRUG DISCOVERY; HUMANS; VACCINATION; VACCINES, ATTENUATED;

EID: 84896721662     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201014666131226123016     Document Type: Article

References (120)

1. Corbel, M.J. Brucellosis: An overview. Emer. Infect. Dis. J., 1997, 3, 213-221.
2. Bruce, D. Note on the discovery of a microorganism in malta fever. Practitioner, 1887, 39, 161-170.
3. Enright, F.M. The pathogenesis and pathobiology of brucella infection in domestic animals. animal brucellosis (mielsen k & duncan jr, eds), 1990, pp. 301-320. CRC Press Inc., Boston.
4. Nicoletti, P. The epidemiology of bovine brucellosis. Adv. Veter. Sci. Compar. Med., 1980, 24, 69-98.
5. Tittarelli, M.; Di Ventura, M.; De Massis, F.; Scacchia, M.; Giovannini, A.; Nannini, D.; Caporale, V. The persistence of brucella melitensis in experimentally infected ewes through three reproductive cycles. J. Veter. Med. B, Infect. Dis. Veter. Public Health, 2005, 52, 403-409.
6. Wilesmith, J.W. The persistence of brucella abortus in calves: A retrospective study of heavily infected herds. Veter. Rec., 1978, 103(8), 149-53.
7. Samartino, L.E.; Enright, F.M. Pathogenesis of abortion of bovine brucellosis. Compar. Immunol., Microbiol. Infect. Dis., 1993, 16(2), 95-101.
8. Sarinas, P.S.A.; Chitkara, K. Brucellosis. Semin. Res.Infect., 2003, 18, 168-182.
9. Pappas, G.; Akritidis, N.; Bosilkovski, M.; Tsianos, E. Brucellosis. New Engl. J. Med., 2005, 352, 2325-2336.
10. Shumilov, K.V.; Sklyarov, O.; Klimanov, A. Designing vaccines against cattle brucellosis. Vaccine, 2010, 28, F31-F34.
11. Cousins, D.V.; Roberts, J.L. Australia's campaign to eradicate bovine tuberculosis: The battle for freedom and beyond. Tuberculosis (Edinb), 2001, 81, 5-15.
12. Lewis, A.E. Brucellosis eradication in Canada. P. Annu. Meeting US An. Health, 1978, 82, 137-138.
13. Davidson, R.M. Control and eradication of animal diseases in New Zealand. New Zeal. Vet. J., 2002, 50, 6-12.
14. Bjorkman, G.; Bengtson, H. Eradication of bovine brucellosis in Sweden. J. Am. Veter. Med. Assoc., 1962, 140, 1192-1195.
15. Fritzsche, K. Results of the eradication of an outbreak of swine brucellosis in the pfalz, Germany. Dtsch tierarztl wochenschr, 1966, 73, 499-502.
16. Van Waveren, G.M. The value of the complement fixation test for the eradication of bovine brucellosis in the Netherlands. Bull. Off. Int. Epiz, 1965, 63, 1015-1024.
17. Godfroid, J.; Käsbohrer, A. Brucellosis in the European Union and Norway at the turn of the twenty-first century. Veter. Microbol., 2002, 90, 135-145.
18. Erkintalo, M.L.; Simula, I. Brucellosis and its eradication from Finland. Duodecim, 1976, 92, 477-483.
19. Poester, F.P.; Gonçalves, V.S.; Lage, A.P. Brucellosis in Brazil. Veter. Microbol., 2002, 90(1-4), 55-62.
20. Samartino, L.E. Brucellosis in Argentina. Veter. Microbol., 2002, 90(1-4), 71-80.
21. Elberg, S. Rev.1 brucella melitensis vaccine. Part III 1981-1995. Vet. Bull., 1996, 66, 1193-1200.
22. Nicoletti, P. Vaccination. In: Nielsen K and Duncan JR eds., Animal brucellosis. CRC Press, Inc., Boca Raton, Fla., 1990a, 283-299.
23. Nicoletti, P. Vaccination against Brucella. Adv. Biotechnol. Proc., 1990b, 13, 147-168.
24. Van Drimmelen, C.; Horwell, F.D. Preliminary findings with the use of brucella melitensis rev.1 as a vaccine against brucellosis in cattle. Bull. Off. Int. Epiz, 1964, 62, 987.
25. Horwell, F.D.; Van Drimmelen, G.G. Brucella melitensis strain rev.1 as a vaccine in cattle. J. S. Afr. Veter. Assoc., 1971, 42, 233-235.
26. Garcia-Carrillo, C. Comparison of brucella melitensis rev.1 and b. abortus strain 19 as a vaccine against brucellosis in cattle. zentralbl. Veterinaermedicine, 1980, 27, 131-138.
27. Verger, J.M.; Grayon, M.; Zundel, E.; Lechopier, P.; Olivier-Bernardin, V. Comparison of the efficacy of brucella suis strain 2 and brucella melitensis rev. 1 live vaccines against a brucellamelitensis experimental infection in pregnant ewes. Vaccine, 1995, 13, 191-196.
28. Blasco, J.M.; Marín, C.; Jiménez de Bagüés, M.P.; Barberán, M. Efficacy of brucella suis strain 2 vaccine against brucella ovis in rams. Vaccine, 1993, 11, 1291-1294.
29. Shang, D.Q.; Xiao, D.L.; Yin, J.M. Epidemiology and control of brucellosis in China. Veter. Microbol., 2002, 90, 165-182.
30. Schurig, G.G.; Roop, R.M.; Bagchi, T.; Boyle, S.; Buhrman, D.; Sriranganathan, N.M. Biological properties of RB51; a stable rough strain of brucella abortus. Veter. Microbol., 1991, 28, 171-188.
31. Moriyón, I.; Grilló, M.J.; Monreal, D.; González, D.; Marín, C.; López-Goñi, I.; Mainar-Jaime, R.C.; Moreno, E.; Blasco, J.M. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Veter. Res., 2004, 5(1), 1-38.
32. Schurig, G.G.; Sriranganathan, N.; Corbel, M.J. Brucellosis vaccines: past, present and future. Veter. Microbol., 2002, 90, 479-496.
33. Olsen, S.C.; Evans, D.; Hennager, S.G.; Cheville, N.F.; Stevens, M.G. Serologic responses of Brucella abortus strain 19 calfhoodvaccinated cattle following adult vaccination with strain RB51. J. vet. Diagn. Invest., 1996, 8(4), 451-454.
34. Stevens, M.G.; Hennager, S.G.; Olsen, S.C.; Cheville, NF. Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with brucella abortus 19 or RB51. J. Clin. Microbol., 1994, 32(4), 1065-1066.
35. Kirandjiski, T.; Nikolovska, G.; Nakova, E.; Smilenovska, B.; Strojmanovska, B.; Naletoski,I.; Mitrov, D. brucellosis control in small ruminants in the republic of macedonia. Prilozi, 2010, 31, 181-190.
36. Smits, H.L. Brucellosis in pastoral and confined livestock: prevention and vaccination. Rev. sci. tech., 2013, 32, 219-228.
37. Ariza, J. Brucellosis: an update. The perspective from the mediterranean basin. Rev. Med. Microbol., 1999, 10.
38. Perkins, S.D.; Smither, S.J.; Atkins, H.S. Towards a brucella vaccine for humans. FEMS microbiol. rev., 2010, 34(3), 379-394.
39. Lopez-Merino, A.; Asselineau, J.; Serre, A.; Roux, J.; Bascoul, S.; Lacave, C. Immunization by an insoluble fraction extracted from brucella melitensis: Immunological and chemical characterization of the active substances. Infect. Immun., 1976, 13, 311-321.
40. Dranovskaya, E.A. New approaches to brucellosis vaccination of people with high risk of infection. Brucella and brucellosis in man and animals (tumbay e, hilmi s & ang o, eds), 1991, pp. 87-100. Ege University Press, Imzir, Turk. Microbiol. Soc.
41. Rasooly, G.; Boros, D.L.; Gerichter, C. Immunization against brucella with killed vaccines. J. Med. Sci., 1968, 4, 246-251.
42. Renoux, G.; Renoux, M.; Tinelli, R. Phenol water fractions from smooth brucella abortus and brucella melitensis: immunochemical analysis and biological behaviour. J. Infect. Dis., 1973, 127, 139-148.
43. Hadjichristodoulou, C.; Voulgaris, P.; Toulieres, L.; Babalis, T.; Manetas, G.; Goutziana, G.; Kastritis, I.; Tselentis, I. Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis. Euro. J. Clin. Microbol. Infect. Dis., 1994, 13, 129-134.
44. Jacques, I.; Olivier-Bernardin, V.; Dubray, G. Induction of antibody and protective responses in mice by Brucella Opolysaccharide-BSA conjugate. Vaccine, 1991, 9, 896-900.
45. Adams, L.G. Development of live Brucella vaccines. In: Adams LG ed., Advances in brucellosis Research. Texas A&M University Press, 1990, 250-276.
46. Oliveira, S.C.; Macedo, G.C.; de Almeida, L.A.; de Oliveira, F.S.; Oñate, A.; Cassataro, J.; Giambartolomei, G.H. Recent advances in understanding immunity against brucellosis: Application for vaccine development. Open Vet. Sci. J., 2010, 4, 102-108
47. Arenas-Gamboa, A.M.; Ficht, T.A.; Kahl-McDonagh, M.M.; Gomez, G.; Rice-Ficht, A.C. The brucella abortus s19 deltavjbr live vaccine candidate is safer than s19 and confers protection against wild-type challenge in balb/c mice when delivered in a sustainedrelease vehicle. Infect. Immun., 2009, 77(2), 877-884.
48. Arenas-Gamboa, A.M.; Rice-Ficht, A.C.; Fan, Y.; Kahl-McDonagh, M.M.; Ficht, T.A. Extended safety and efficacy studies of the attenuated brucella vaccine candidates 16 m(delta)vjbr and s19(delta)vjbr in the immunocompromised irf-1-/-mouse model. Clin. vaccine immunol., 2012, 19(2), 249-260.
49. Briones, G.; Iñón de Iannino, N.; Roset, M.; Vigliocco, A.; Paulo, P.S.; Ugalde, R.A. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in hela cells. Infect. Immun., 2001, 69(7), 4528-4535.
50. Tibor, A. Jacques, I.; Guilloteau, L.; Verger, J.M.; Grayon, M.; Wansard, V.; Letesson, J.J. Effect of P39 gene deletion in live brucella vaccine strains on residual virulence and protective activity in mice. Infect. Immun., 1998, 66(11), 5561-5564.
51. Blasco, J.M. A review of the use of b.melitensis rev.1 vaccine in adult sheep and goats. Prev. vet. Med., 1997, 31, 275-283.
52. Al-Khalaf, S.A.; Taha Mohamad, B.; Nicoletti, P. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with brucella abortus strain 19 or brucella melitensis strain rev.1. Trop. Anim. health pro., 1992, 24, 45-49.
53. Herr, S.; Bosman, P.P.; Ehret, W.J.; Te Brugge, L.A.; Williamson, C.C.; Pieterson, P.M. Brucellosis serology: Reduced dose s19 vaccination of yearling heifers versus the use of the standard dose at 5-7 months of age in a clean herd. J. S. Afr. Veter. Assoc., 1986, 57(4), 215-219.
54. Vemulapall, R.; He, Y.; Cravero, S.; Sriranganathan, N.; Stephen M. Boyle, Gerhardt G. Schurig. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of brucella abortus strain rb51. Infect. Immun., 2000, 68(6), 3286-3289.
55. Vemulapall, R.; He, Y.; Larissa S. Buccolo, Stephen M. Boyle, Nammalwar, Sriranganathan, Gerhardt G. Schurig. Complementation of brucella abortus rb51 with a functional wboa gene results in oantigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect. Immun., 2000, 68(7), 3927-3932.
56. Rajasekaran, P., Surendran, N., Seleem, M.N.; Sriranganathan, N.; Schurig, G.G.; Boyle, S.M. Over-expression of homologous antigens in a leucine auxotroph of brucella abortus strain RB51 protects mice against a virulent B. suis challenge. Vaccine, 2011, 29(17), 3106-3110.
57. Jacques, I.; Verger, J.M.; Laroucau, K.; Grayon, M.; Vizcaíno, N.; Peix, A. Immunological responses and protective efficacy against brucella melitensis induced by bp26 and omp31 B. Melitensis rev.1 deletion mutants in sheep. Vaccine, 2007, 25, 794-805.
58. Fiorentino, M.A.; Campos, E.; Cravero, S.; Arese, A.; Paolicchi, F.; Campero, C. Protection levels in vaccinated heifers with experimental vaccines brucella abortus M1-luc and INTA 2. Veter. Microbol., 2008, 132, 302-311.
59. Carlos, Chacón-Díaza, B.; Melissa, Muñoz-Rodrígueza; Elías, Barquero-Calvoa; Caterina, Guzmán-Verria; Esteban, Chaves-Olartea, B.; María, Jesús, Grilló, C.; Edgardo, Morenoa, D. The use of green fluorescent protein as a marker for brucella vaccines. Vaccine, 2011, 29, 577-582.
60. Wu, Q.; Pei, J.; Turse, C.; Ficht, T.A. Mariner mutagenesis of brucella melitensis reveals genes with previously uncharacterized roles in virulence and survival. BMC Microbiology, 2006, 6, 102.
61. Lowry, J.E.; Isaak, D.D.; Leonhardt, J.A.; Vernati, G.; Pate, J.C. Vaccination with brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection. Plos one, 2011, 6, e17425.
62. Tian, M.; Qu, J.; Han, X.; Zhang, M.; Ding, C.; Ding, J.; Chen, G.; Yu, S. microarray-based identification of differentially expressed genes in intracellular brucella abortus within raw264.7 cells. Plos one, 2013, 8(8), e67014.
63. He, Y. Analyses of Brucella Pathogenesis, Host Immunity, and Vaccine Targets using Systems Biology and Bioinformatics. Frontiers cell. infect. microbiol., 2012, 2, 2.
64. Foulongne, V.; Walravens, K.; Bourg, G.; Boschiroli, M.L.; Godfroid, J.; Ramuz, M.; O'Callaghan, D. Aromatic compounddependent brucella suis is attenuated in both cultured cells and mouse models. Infect. Immun., 2001, 69(1), 547-550.
65. Lavigne, J.P.; Patey, G.; Sangari, F.J.; Bourg, G.; Ramuz, M.; O'Callaghan, D.; Michaux-Charachon, S. Identification of a new virulence factor, bvfa, in brucella suis. infect. Immun., 2005, 73(9), 5524-5529.
66. Phillips, R.W.; Elzer, P.H.; Robertson, G.T.; Hagius, S.D.; Walker, J.V.; Fatemi, M.B.; Enright, F.M.; Roop, R.M 2nd. A brucella melitensis high-temperature-requirement a (htra) deletion mutant is attenuated in goats and protects against abortion. Res. Vet. Sci., 1997, 63(2), 165-167.
67. Roop, R.M 2nd., Phillips, R.W.; Hagius, S.; Walker, J.V.; Booth, N.J.; Fulton, W.T.; Edmonds, M.D.; Elzer, P.H. Re-examination of the role of the brucella melitensis htra stress response protease in virulence in pregnant goats. Veter. Microbol., 2001, 82(1), 91-95.
68. Loisel-Meyer, S.; Jiménez de Bagüés, M.P.; Bassères, E.; Dornand, J.; Köhler, S.; Liautard, J. P.; Jubier-Maurin, V. Requirement of nord for brucella suis virulence in a murine model of in vitro and in vivo infection. Infect. Immun., 2006, 74(3),1973-6.
69. Kahl-McDonagh, M.M.; Elzer, P.H.; Hagius, S.D.; Walker, J.V.; Perry, Q.L.; Seabury, C.M.; den Hartigh, A.B.; Tsolis, R.M.; Adams, L.G.; Davis, D.S.; Ficht, T.A. Evaluation of novel brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine, 2006, 24(24), 5169-5177.
70. Cheville, N.F.; Olsen, S.C.; Stevens, M.G.; Florance, A.M.; Houng, H.S.; Drazek, E.S.; Warren, R.L.; Hadfield, T.L.; Hoover, D.L. Bacterial persistence and immunity in goats vaccinated with a pure deletion mutant or the parental 16m strain of brucella melitensis. Infect. Immun., 1996, 64(7), 2431-2439.
71. Edmonds, M.D.; Cloeckaert, A.; Hagius, S.D.; Samartino, L.E.; Fulton, W.T.; Walker, J.V.; Enright, F.M.; Booth, N.J.; Elzer, P.H. Pathogenicity and protective activity in pregnant goats of a brucella melitensis Δomp25 deletion mutant. Res. Vet. Sci., 2002, 72(3):235-239.
72. Elzer, P.H.; Enright, F.M.; McQuiston, J.R.; Boyle, S.M.; Schurig, G.G. Evaluation of a rough mutant of brucella melitensis in pregnant goats. Res. Vet. Sci., 1998, 64(3), 259-260.
73. Barrio, M.B.; Grilló, M.J.; Muñoz, P.M.; Jacques, I.; González, D.; de Miguel, M.J.; Marín, C.M.; Barberán, M.; Letesson, J.J.; Gorvel, J.P.; Moriyón, I.; Blasco, J.M.; Zygmunt, M.S. Rough mutants defective in core and o-polysaccharide synthesis and export induce antibodies reacting in anindirect elisa with smooth lipopolysaccharide and are less effective than rev 1 vaccine against brucella melitensis infection of sheep. Vaccine, 2009, 27(11), 1741-1749.
74. Ugalde, J.E.; Comerci, D.J.; Leguizamón, M.S.; Ugalde, R.A. Evaluation of brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine. Infect. Immun., 2003, 71(11), 6264-6269.
75. Yang, X.; Becker, T.; Walters, N.; Pascual, D.W. Deletion of znuA virulence factor attenuates brucella abortus and confers protection against wild-type challenge. Infect. Immun., 2006, 74(7), 3874-3879.
76. Bellaire, B.H.; Elzer, P.H.; Hagius, S.; Walker, J.; Baldwin, C.L.; Roop, R.M 2nd. Genetic organization and iron-responsive regulation of the brucella abortus 2,3-dihydroxybenzoic acid biosynthesis operon, a cluster of genes required for wild-type virulence in pregnant cattle. Infect. Immun., 2003, 71(4), 1794-1803.
77. Golding, B.; Scott, D.E.; Scharf, O.; Huang, L.Y.; Zaitseva, M.; Lapham, C.; Eller, N.; Golding, H.Immunity and protection against brucella abortus. Microbes Infect., 2001, 3(1), 43-48.
78. Araya, L.N.; Elzer, P.H.; Rowe, G.E.; Enright, F.M.; Winter, A.J. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with brucella abortus. J. Immun., 1989, 143(10), 3330-3337.
79. Dornand, J.; Gross, A.; Lafont, V.; Liautard, J.; Oliaro, J.; Liautard, J.P. The innate immune response against brucella in humans. Veter. Microbol., 2002, 90, 383-394.
80. Jiang, X.; Baldwin, C.L. Effects of cytokines on intracellular growth of brucella abortus. Infect. Immun., 1993, 61(1), 124-134.
81. Casadevall, A.; Pirofski, L.A. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv. Immun., 2006, 91, 1-44.
82. Goenka, R.; Parent, M.A.; Elzer, P.H.; Baldwin, C.L. B celldeficient mice display markedly enhanced resistance to the intracellular bacterium brucella abortus. J. Infect. Dis., 2011, 203(8), 1136-1146.
83. Montaraz, J.A.; Winter, A.J.; Hunter, D.M.; Sowa, B.A.; Wu, A.M.; Adams, L.G. Protection against brucella abortus in mice with o-polysaccharide-specific monoclonal antibodies. Infect. Immun., 1986, 51, 961-963.
84. Winter, A.J.; Duncan, J.R.; Santisteban, C.G.; Douglas, J.T.; Adams, L.G. Capacity of passively administered antibody to prevent establishment of brucella abortus infection in mice. Infect. Immun., 1989, 57, 3438-3444.
85. Phillips, M.; Deyoe, B.L.; Canning, P.C. Protection of mice against brucella abortus infection by inoculation with monoclonal antibodies recognizing brucella o-antigen. Am. J. Veter. Res., 1989, 50, 2158-2161.
86. Barquero-Calvo, E.; Chaves-Olarte, E.; Weiss, D.S.; Guzmán-Verri, C.; Chacón-Díaz,C.; Rucavado, A. brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. Plos one, 2007, 2, e631.
87. Palacios-Chaves, L.; Conde-Álvarez, R.; Gil-Ramírez, Y.; Zuñiga-Ripa, A.; Barquero-Calvo, E.; Chacón-Díaz, C. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen-associated molecular pattern. Plos one, 2011, 6, e16030.
88. Raquel, Conde-Álvareza; Vilma, Arce-Gorvelb; Yolanda, Gil-Ramíreza; Maite, Iriartea; María-Jesús, Grillóc; Jean, Pierre, Gorvelb Ignacio Moriyóna. Lipopolysaccharide as a target for brucellosis vaccine design. Microb. Pathogenesis, 2013, 58, 29-34.
89. Yu, D.H.; Hu, X.D.; Cai, H.; Li, M. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against brucella abortus 2308 by inducing specific CTL responses. DNA cell biol., 2007, 26(6), 435-443.
90. Pasquevich, K.A.; Estein, S.M.; García Samartino, C.; Zwerdling, A.; Coria, L.M.; Barrionuevo, P.; Fossati, C.A.; Giambartolomei, G.H.; Cassataro, J. Immunization with recombinant brucella species outer membrane protein omp16 or omp19 in adjuvant induces specific cd4+ and cd8+ t cells as well as systemic and oral protection against brucella abortus infection. Infect. Immun., 2009, 77(1), 436-445.
91. Commander, N.J.; Spencer, S.A.; Wren, B.W.; MacMillan, A.P. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding brucella melitensis 16m genes. Vaccine, 2007, 5(1), 43-54.
92. Grilló, M.J.; Manterola, L.; de Miguel, M.J.; Muñoz, P.M.; Blasco, J.M.; Moriyón, I.; López-Goñi, I. Increases of efficacy as vaccine against brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrs/bvrr and rough wbka mutants. Vaccine, 2006, 24(15), 2910-2916.
93. Liu, W.; Jing, Z.; Ou, Q.; Cui, B.; He, Y.; Wu, Q. Complete genome sequence of brucella melitensis biovar 3 strain ni, isolated from an aborted bovine fetus. J. Bacteriol., 2012, 194(22), 6321.
94. Yang, X. H.; Skyberg, J. A.; Cao, L.; Clapp, B.; Thornburg, T.; Pascual, D. W. Progress in brucella vaccine development. Front Biol. (Beijing), 2013, 8(1), 60-77.
95. Kahl-McDonagh, M.M.; Ficht, T.A. Evaluation of protection afforded by brucella abortus and brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in Balb/C mice. Infect. Immun., 2006, 74(7), 4048-4057.
96. Arenas-Gamboa, A.M.; Rice-Ficht, A.C.; Kahl-McDonagh, M.M.; Ficht, T.A. Protective efficacy and safety of brucella melitensis 16mδmucr against intraperitoneal and aerosol challenge in balb/c mice. Infect. Immun., 2011, 79(9), 3653-3658.
97. Cheville, N.F.; Stevens, M.G.; Jensen, A.E.; Tatum, F.M.; Halling, S.M. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Veter. Res., 1993, 54(10), 1591-1597.
98. Trant, C.G.; Lacerda, T.L.; Carvalho, N.B.; Azevedo, V.; Rosinha, G.M.; Salcedo, S.P.; Gorvel, J.P.; Oliveira, S.C. The brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect. Immun., 2010, 78(5), 2283-2291.
99. Izadjoo, M.J.; Bhattacharjee, A.K.; Paranavitana, C.M.; Hadfield, T.L.; Hoover, D.L. Oral vaccination with brucella melitensis wr201 protects mice against intranasal challenge with virulent brucella melitensis 16m. Infect. Immun., 2004, 72(7), 4031-4039.
100. Lacerda, T.L.; Cardoso, P.G.; Augusto de Almeida, L.; Camargo, I.L.; Afonso, D.A.; Trant, C.C.; Macedo, G.C.; Campos, E.; Cravero, S.L.; Salcedo, S.P.; Gorvel, J.P.; Oliveira, S.C. Inactivation of formyltransferase (wbkc) gene generates a brucella abortus rough strain that is attenuated in macrophages and in mice. Vaccine, 2010, 28(34), 5627-5634.
101. Bricker, B.J.; Tabatabai, L.B.; Deyoe, B.L.; Mayfield, J.E. Conservation of antigenicity in a 31-kDa brucella protein. Veter. Microbol., 1988, 18, 313-325.
102. Debbarh, H.S.; Zygmunt, M.S.; Dubray, G.; Cloeckaert, A. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis rev.1 vaccinated sheep. Veter. Microbol., 1996, 53, 325-337.
103. Rossetti, O.L.; Arese, A.I.; Boschiroli, M.L.; Cravero, S.L. Cloning of brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: Potential use for diagnosis. J. Clin. Microbol., 1996, 34, 165-169.
104. Vizcaino, N.; Zygmunt, M.S.; Verger, J.M.; Grayon, M.; Cloeckaert, A. Localization and characterization of a specific linear epitope of the Brucella DnaK protein. FEMS microbiol. Lett., 1997, 154, 117-122.
105. Roop, R.M.; Fletcher, T.W.; Sriranganathan, N.M.; Boyle, S.M.; Schurig G.G. Identification of an immunoreactive brucella abortus htra stress response protein homolog. Infect. Immun., 1994, 62, 1000-1007.
106. Oliveira, S.C.; Harms, J.S.; Banai, M.; Splitter, G.A. Recombinant brucella abortus proteins that induce proliferation and gammainterferon secretion by cd4 t cells from brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell. immunol., 1996, 172, 262-268.
107. Oliveira, S.C.; Splitter, G.A. Subcloning and expression of the brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect. Immun., 1994, 62, 5201-5204.
108. Oliveira, S.C.; Splitter, G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against brucella abortus infection. Vaccine, 1996, 14, 959-962.
109. Kovach, M.E.; Elzer, P.H.; Robertson, G.T.; Chirhart-Gilleland, R.L.; Christensen, M.A.; Peterson, K.M.; Roop, R.M. Cloning and nucleotide sequence analysis of a brucella abortus gene encoding an 18 kda immunoreactive protein. Microb. pathogenesis, 1997, 22, 241-246.
110. Bowden, R.A.; Cloeckaert, A.; Zygmunt, M.S.; Dubray, G. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of brucella melitensis (omp25) expressed in escherichia coli. J. Med. Microbiol., 1998, 47, 39-48.
111. Lindler, L.E.; Hadfield, T.L.; Tall, B.D.; Snellings, N.J.; Rubin, F.A.; Van De Verg, L.L.; Hoover, D.; Warren, R.L. Cloning of a brucella melitensis group 3 antigen gene encoding omp28, a protein recognized by the humoral immune response during human brucellosis. Infect. Immunity, 1996, 64, 2490-2499.
112. Kittelberger, R.; Hilbink, F.; Hansen, M.F.; Ross, G.P.; de Lisle, G.W.; Cloeckaert, A.; de Bruyn, J. Identification and characterization of immunodominant antigens during the course of infection with brucella ovis. J. Veter. Diagn. Invest., 1995, 7, 210-218.
113. Al-Mariri, A.; Tibor, A.; Mertens, P.; De Bolle, X.; Michel, P.; Godefroid, J.; Walravens, K.; Letesson, J.J. Protection of BALB/c mice against brucella abortus 544 challenge by vaccination with bacterioferritin or p39 recombinant proteins with cpg oligodeoxynucleotides as adjuvant. Infect. Immunity, 2001, 69, 4816-4822.
114. Denoel, P.A.; Vo, T.K.; Tibor, A.; Weynants, V.E.; Trunde, J.M.; Dubraym, G.; Limet, J.E.; Letesson, J.J. Characterization, occurrence, and molecular cloning of a 39-kilodalton brucella abortus cytoplasmic protein immunodominant in cattle. Infect. Immunity, 1997, 65, 495-502.
115. Stevens, M.G.; Tabatabai, L.B.; Olsen, S.C.; Cheville, N.F. Immune responses to superoxide dismutase and synthetic peptides of superoxide dismutase in cattle vaccinated with brucella abortus strain 19 or RB51. Veter. Microbiol., 1994, 41, 383-389.
116. Tabatabai, L.B.; Pugh, Jr. J. W. Modulation of immune responses in Balb/c mice vaccinated with brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine, 1994, 12, 919-924.
117. Tan, W.; Wang, X.R.; Nie, Y.; Wang, C.; Cheng, L.Q.; Wang, X.C.; Zhang, R.; Yan, G.M. Recombinant VirB5 protein as a potential serological marker for the diagnosis of bovine brucellosis. Mol. Cell. probe., 2012, 26(3), 127-131.
118. Rolán, H.G.; den Hartigh, A.B.; Kahl-McDonagh, M.; Ficht, T.; Adams, L.G.; Tsolis, R.M. VirB12 is a serological marker of brucella infection in experimental and natural hosts. Clin. V Immun., 2008, 15(2), 208-214.
119. Castañeda-Roldán, E.I.; Ouahrani-Bettache, S.; Saldaña, Z.; Avelino, F.; Rendón, M.A.; Dornand, J.; Girón, J.A. Characterization of SP41, a surface protein of brucella associated with adherence and invasion of host epithelial cells. Cell. Microbiol., 2006, 8(12), 1877-1887.
120. Bosseray, N.; Plommet, M. Brucella suis s2, brucella melitensis rev 1 and brucella abortus s19 living vaccines: residual virulence and immunity induced against three brucella species challenge strains in mice. Vaccine, 1990, 8, 462-468.